Javascript must be enabled to continue!
Is 24/7 Remote Patient Management in Heart Failure Necessary? Results of the Telemedical Emergency Service Used in the TIM-HF and in the TIM-HF2 Trials
View through CrossRef
Abstract
Aims
Telemedical emergency services for heart failure (HF) patients are usually provided during business hours. However, many emergencies occur outside of business hours. This study evaluates if a 24/7 telemedical emergency service is needed for the remote management of high-risk HF patients.
Methods and results
The study included 1119 patients merged from the TIM-HF and TIM-HF2 trials [age 69 ± 11, 73% male, left ventricular ejection fraction 37% ± 13, 557 New York Heart Association (NYHA) II/562 NYHA III]. Patients received a 24/7 physician-guided emergency service provided by the telemedical centre (TMC) in addition to remote management within business hours. During emergency calls, patient status, symptoms, electronic patient record, and instant telemonitoring data were evaluated by the TMC physician. Following diagnosis, patients were referred for hospital admission or instructed to stay at home. Apart from the TMC, patients could place a call to the public emergency service at any time.
Seven hundred sixty-eight emergency calls were placed over 1383 patient years (0.56 calls/patient year). Five hundred twenty-six calls (69%) occurred outside business hours. There were 146 (19%) emergency calls for worsening HF, 297 (39%) other cardiovascular, and 325 (42%) non-cardiac causes, with a similar pattern inside and outside business hours. Of the 1119 patients, 417 (37%) placed at least one emergency call. Patients with NYHA Class III, higher N-terminal prohormone of brain natriuretic peptide (>1.400 pg/mL) levels, ischaemic aetiology of HF, implanted defibrillator, and impaired renal function had a higher probability of placing emergency calls. During study follow-up, patients who made an emergency call had a higher all-cause mortality (22% vs. 11%, P = 0.007 in TIM-HF; 16% vs. 4%, P < 0.001 in TIM-HF2) and more unplanned hospitalizations (324 vs. 162, P < 0.001 in TIM-HF; 545 vs. 180, P < 0.001 in TIM-HF2). Of the total 1,211 unplanned hospital admissions, 492 (41%) were initiated by a patient emergency call.
Three hundred seventy-nine calls (49%) were placed to the TMC, whereas 389 calls (51%) were made to the public emergency service. Three hundred twenty-six (84%) of the calls to the public emergency service resulted in acute hospitalizations.
The TMC initiated 202 (53%) hospital admissions; 177 (47%) patients were advised to stay at home. All patients that remained at home were alive during a prespecified safety period of 7 days post-call. Diagnoses made by the TMC physician were confirmed in 83% of cases by the hospital.
Conclusion
A telemedical emergency service for high-risk HF patients is safe and should operate 24/7 to reduce unplanned hospitalizations. Emergency calls could be considered as a marker for higher morbidity and mortality.
Oxford University Press (OUP)
Title: Is 24/7 Remote Patient Management in Heart Failure Necessary? Results of the Telemedical Emergency Service Used in the TIM-HF and in the TIM-HF2 Trials
Description:
Abstract
Aims
Telemedical emergency services for heart failure (HF) patients are usually provided during business hours.
However, many emergencies occur outside of business hours.
This study evaluates if a 24/7 telemedical emergency service is needed for the remote management of high-risk HF patients.
Methods and results
The study included 1119 patients merged from the TIM-HF and TIM-HF2 trials [age 69 ± 11, 73% male, left ventricular ejection fraction 37% ± 13, 557 New York Heart Association (NYHA) II/562 NYHA III].
Patients received a 24/7 physician-guided emergency service provided by the telemedical centre (TMC) in addition to remote management within business hours.
During emergency calls, patient status, symptoms, electronic patient record, and instant telemonitoring data were evaluated by the TMC physician.
Following diagnosis, patients were referred for hospital admission or instructed to stay at home.
Apart from the TMC, patients could place a call to the public emergency service at any time.
Seven hundred sixty-eight emergency calls were placed over 1383 patient years (0.
56 calls/patient year).
Five hundred twenty-six calls (69%) occurred outside business hours.
There were 146 (19%) emergency calls for worsening HF, 297 (39%) other cardiovascular, and 325 (42%) non-cardiac causes, with a similar pattern inside and outside business hours.
Of the 1119 patients, 417 (37%) placed at least one emergency call.
Patients with NYHA Class III, higher N-terminal prohormone of brain natriuretic peptide (>1.
400 pg/mL) levels, ischaemic aetiology of HF, implanted defibrillator, and impaired renal function had a higher probability of placing emergency calls.
During study follow-up, patients who made an emergency call had a higher all-cause mortality (22% vs.
11%, P = 0.
007 in TIM-HF; 16% vs.
4%, P < 0.
001 in TIM-HF2) and more unplanned hospitalizations (324 vs.
162, P < 0.
001 in TIM-HF; 545 vs.
180, P < 0.
001 in TIM-HF2).
Of the total 1,211 unplanned hospital admissions, 492 (41%) were initiated by a patient emergency call.
Three hundred seventy-nine calls (49%) were placed to the TMC, whereas 389 calls (51%) were made to the public emergency service.
Three hundred twenty-six (84%) of the calls to the public emergency service resulted in acute hospitalizations.
The TMC initiated 202 (53%) hospital admissions; 177 (47%) patients were advised to stay at home.
All patients that remained at home were alive during a prespecified safety period of 7 days post-call.
Diagnoses made by the TMC physician were confirmed in 83% of cases by the hospital.
Conclusion
A telemedical emergency service for high-risk HF patients is safe and should operate 24/7 to reduce unplanned hospitalizations.
Emergency calls could be considered as a marker for higher morbidity and mortality.
Related Results
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Remote Patient Management of Heart Failure Across the Ejection Fraction Spectrum: A Pre-Specified Analysis of the TIM-HF2 Trial
Remote Patient Management of Heart Failure Across the Ejection Fraction Spectrum: A Pre-Specified Analysis of the TIM-HF2 Trial
Abstract
Aims
The benefit of non-invasive remote patient management (RPM) for patients with heart failure (HF) has been d...
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
Fluoridobromate(V)–hydrogen fluoride cocrystals
Fluoridobromate(V)–hydrogen fluoride cocrystals
Cocrystals of BrF5 and HF2− salts have been obtained for the first time in the form of the two compounds [NMe4][(BrF5)6(HF2)] and Cs2[(BrF5)6(HF2)(H2F3)]. These compounds are forme...
PATOMEKANISME PENYAKIT GAGAL JANTUNG KONGESTIF
PATOMEKANISME PENYAKIT GAGAL JANTUNG KONGESTIF
Heart failure is a clinical syndrome characterized by abnormalities in the structure or function of the heart, resulting in inability of heart to pump blood to meet the metabolic n...
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
The Effects of Xanthine Oxidase Inhibitors on the Management of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the fastest-growing cause of death around the world, and atherosclerosis plays a major role in the etiology of CVDs. The most recent figures show...

